◆英語タイトル:Insulet Corp (PODD) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10102
◆発行会社(調査会社):
GlobalData
◆発行日:2018年11月
◆ページ数:32
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
※
販売価格オプションの説明はこちらで、
ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※
GlobalData社の概要はこちらでご確認いただけます。
【レポートの概要】
Summary
Insulet Corp (Insulet) is a medical device company that develops, manufactures and distributes insulin management systems for diabetic patients. Its OmniPod insulin management system is a continuous insulin delivery system for insulin dependent diabetic s. Omnipod system consists of a disposable self-adhesive tubeless insulin infusion device, OmniPod, and a handheld wireless device, Personal Diabetes Manager. The company also works in partnership with biotechnology and pharmaceutical companies that utilize the customized form of its Omnipod system to deliver drugs at specified intervals of time at predetermined doses. The company markets and sells its products directly and through distribution partners in North America, Asia and Europe. Insulet is headquartered in Billerica, Massachusetts, the US.
Insulet Corp (PODD) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.
Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Insulet Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Insulet Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Insulet Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Insulet Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Insulet Corp, Medical Devices Deals, 2012 to YTD 2018 9
Insulet Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Insulet Corp, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
Insulet Acquires Distribution Rights from GlaxoSmithKline 11
Debt Offering 12
Insulet Raises Private Placement of Senior Notes for USD345 Million 12
Insulet Prices Public Offering of 2% Notes Due 2019 for USD175 Million 13
Asset Transactions 15
Sinoxa Pharma Acquires Patent Rights To Omnipod Patch-Pump Technology From Insulet 15
Insulet Corp – Key Competitors 16
Insulet Corp – Key Employees 17
Insulet Corp – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Recent Developments 19
Financial Announcements 19
Nov 01, 2018: Insulet reports third quarter 2018 revenue of $151.1 million, up 24% year-over-year, and gross margin over 67%, up 700 basis points 19
Aug 02, 2018: Insulet Reports second quarter 2018 revenue of $124.3 million, up 13% year-over-year, and gross margin of 66%, up 710 basis points 20
May 03, 2018: Insulet Reports First Quarter 2018 Financial Results 21
Nov 02, 2017: Insulet Reports Third Quarter 2017 Financial Results 23
Aug 03, 2017: Insulet Reports Second Quarter 2017 Financial Results 24
May 08, 2017: Insulet Reports First Quarter 2017 Financial Results 25
Feb 27, 2017: Insulet Reports Fourth Quarter and Full Year 2016 Financial Results 26
Corporate Communications 28
Sep 10, 2018: Insulet announces Shacey Petrovic, President and COO, promoted to CEO, effective January 1, 2019; Patrick Sullivan will retire as Chairman and CEO at the end of 2018 28
Aug 10, 2017: Insulet Appoints Michael R. Minogue and James C. Mullen to Board of Directors 30
May 30, 2017: Insulet Appoints Bret Christensen as Chief Commercial Officer 31
Appendix 32
Methodology 32
About GlobalData 32
Contact Us 32
Disclaimer 32
List of Tables
Insulet Corp, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Insulet Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Insulet Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Insulet Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Insulet Corp, Deals By Therapy Area, 2012 to YTD 2018 8
Insulet Corp, Medical Devices Deals, 2012 to YTD 2018 9
Insulet Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Insulet Acquires Distribution Rights from GlaxoSmithKline 11
Insulet Raises Private Placement of Senior Notes for USD345 Million 12
Insulet Prices Public Offering of 2% Notes Due 2019 for USD175 Million 13
Sinoxa Pharma Acquires Patent Rights To Omnipod Patch-Pump Technology From Insulet 15
Insulet Corp, Key Competitors 16
Insulet Corp, Key Employees 17
Insulet Corp, Other Locations 18
Insulet Corp, Subsidiaries 18
List of Figures
Insulet Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Insulet Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Insulet Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Insulet Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Insulet Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Insulet Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Insulet Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Insulet Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Insulet Corp, Medical Devices Deals, 2012 to YTD 2018 9